Neurology Central

While we wait for effective treatments, what else can research deliver for people with dementia?

0

Driving change with bold ambitions

With no way to slow down or stop the diseases that cause dementia and almost 50 million people living with the condition worldwide [1], it is set to be the 21st century’s biggest killer. At the first G8 Summit on dementia in 2013, world leaders made a bold pledge – to find the first disease-modifying treatment by 2025. This shared ambition has sparked a number of positive actions to boost the research landscape, including enhancing international coordination [2,3], review of drug regulation policy [4,5] and significant increases in investment for biomedical research (i.e., US$100 million global established, £250 million investment for the UK Dementia Research Institute and the US dementia research funding budget increased from US$504 million in 2013 to US$1.4 billion in 2017) [6,7]. But as past trial failures have shown us, Alzheimer’s drug development is a tremendously challenging area. Even with these united efforts, we are not guaranteed to deliver an effective treatment in the next 7 years.

Social care in crisis

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share:

Leave A Comment